Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'pi3 kinase p110'

Search results for: 'pi3 kinase p110'

Items 111-120 of 634

Page
per page
  1. SKLB610
    A8237 SKLB610
    Summary: Potent VEGFR inhibitor
      insoluble in H2O; ≥20.75 mg/mL
  2. Dasatinib (BMS-354825)
    A3017 Dasatinib (BMS-354825)
     4 Citation
    Summary: Src and BCR-Abl inhibitor
      ≥24.4 mg/mL
  3. Linifanib (ABT-869)
    A2949 Linifanib (ABT-869)
    Target: VEGFR|PDGFR
    Summary: VEGFR/PDGFR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥18.75 mg/mL
  4. (R)-Crizotinib
    A3020 (R)-Crizotinib
     2 Citation
    Target: c-MET
    Summary: C-MET/ALK inhibitor,potent and ATP-competitve
      insoluble in H2O; insoluble in EtOH; ≥7.51 mg/mL
  5. Dinaciclib (SCH727965)
    A8412 Dinaciclib (SCH727965)
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: Potent CDK inhibitor
  6. Sorafenib Tosylate
    A8245 Sorafenib Tosylate
     1 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥31.85 mg/mL
  7. Imatinib Mesylate (STI571)
    A1805 Imatinib Mesylate (STI571)
    Target: PDGFR|c-Kit|Bcr-Abl
    Summary: Abl/c-kit/PDGFR inhibitor
      ≥29.5 mg/mL
  8. AT7519
    A5719 AT7519
    Target: Cyclin-Dependent Kinases
    Summary: Multi-CDK inhibitor
  9. SNS-032 (BMS-387032)
    A1980 SNS-032 (BMS-387032)
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK inhibitor
      insoluble in H2O; ≥19.05 mg/mL
  10. R547
    A8642 R547
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK1/2/4 inhibitor,ATP-competitive
      Soluble in DMSO

Items 111-120 of 634

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
Clear All
Shopping Options
Category
  1. Proteases 1 item
  2. Apoptosis 21item
  3. Chromatin/Epigenetics 63item
  4. Metabolism 4item
  5. MAPK Signaling 61item
  6. Tyrosine Kinase 221item
  7. DNA Damage/DNA Repair 14item
  8. PI3K/Akt/mTOR Signaling 78item
  9. Microbiology & Virology 1 item
  10. Cell Cycle/Checkpoint 116item
  11. Ubiquitination/ Proteasome 7item
  12. JAK/STAT Signaling 60item
  13. TGF-β / Smad Signaling 70item
  14. Angiogenesis 6item
  15. GPCR/G protein 5item
  16. Stem Cell 12item
  17. Membrane Transporter/Ion Channel 4item
  18. Cancer Biology 6item
  19. Neuroscience 4item
  20. Other Signal Transduction 5item
  21. Others 30item
  22. Immunology/Inflammation 9item
Specificity
  1. Selective 238item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 24item
  2. Irreversible 8item
Target
  1. Cyclin-Dependent Kinases 27item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 4item
  4. PI3K 16item
  5. Raf 10item
  6. Aurora Kinases 21item
  7. CSF-1R 4item
  8. mTOR 8item
  9. FLT3 13item
  10. GSK-3 9item
  11. PLK 6item
  12. Chk 5item
  13. Eph Receptors 3item
  14. VEGFR 30item
  15. PDGFR 22item
  16. c-Kit 12item
  17. RET 4item
  18. IRAK 3item
  19. Bromodomain-containing proteins(BRDs) 1 item
  20. p38 6item
  21. PKB 1 item
  22. JNK 2item
  23. SGK 2item
  24. Bcr-Abl 13item
  25. MEK 4item
  26. FGFR 12item
  27. Pim 4item
  28. Voltage-gated Sodium (NaV) Channels 1 item
  29. Ribosomal s6 kinases (RSK) 1 item
  30. MET 5item
  31. Src 17item
  32. Trk Receptors 2item
  33. STAT 2item
  34. EGFR 18item
  35. ROCK 7item
  36. BTK 1 item
  37. PAK 3item
  38. FAK 4item
  39. BMP and Other Activin Receptors 2item
  40. JAK 15item
  41. Syk 5item
  42. DNA-PK 5item
  43. AMPK 2item
  44. PDHK 1 item
  45. ErbB 4item
  46. S6 kinases 1 item
  47. Adenosine Kinases 2item
  48. ERK 4item
  49. Kinases 1 item
  50. c-MET 5item
  51. PKC 12item
  52. Ubiquitin-specific proteases 1 item
  53. Ca2 /calmodulin-dependent protein kinases (CaMKs) 6item
  54. Lyn 2item
  55. HER2 2item
  56. Pyk2 3item
  57. LRRK2 5item
  58. Insulin and Insulin-like Receptors 3item
  59. ALK 6item
  60. ROS1 1 item
  61. Sphingosine kinases (SphKs) 2item
  62. PKG 2item
  63. PKA 5item
  64. Myosin light chain kinases (MLCKs) 2item
  65. CaM-KK 1 item
  66. MELK 1 item
  67. Insulin-like growth factors (IGFs) 1 item
  68. Clk 1 item
  69. NUAK1 1 item
  70. NUAK2 1 item
  71. MK2 2item
  72. Angiotensin-Converting Enzymes (ACEs) 1 item
  73. Tie-2 2item
  74. RSK 2item
  75. ATM/ATR 4item
  76. CK1 1 item
  77. Farnesyl Diphosphate Synthases 1 item
  78. CK2 3item
  79. HIPK2 1 item
  80. HIPK3 1 item
  81. P2X Receptors 1 item
  82. c-Fyn 1 item
  83. TAK1 1 item
  84. P110 1 item
  85. Hck 2item
  86. MNK 1 item
  87. 5-Lipoxygenases 1 item
  88. Insulin Receptors 1 item
  89. IRG-1R 1 item
  90. eEF-2 1 item
  91. Cdc7 1 item
  92. ZAP-70 1 item
  93. c-RET 3item
  94. p70 rsk 2item
  95. VEGFR3/FLT4 1 item
  96. NTRK1/TRKA 1 item
  97. CSF-1R/c-Fms 1 item
  98. TAM kinase 1 item
  99. KDR 1 item
  100. Fyn kinase 1 item
  101. Abl kinases 1 item
  102. AXL 1 item
  103. c-Fms tyrosine kinase 1 item
  104. insulin 1 item
  105. haspin kinase 1 item
  106. STK 1 item
  107. MSK 1 item
  108. Lyn kinase 1 item
  109. Mer tyrosine kinase 1 item
  110. ErbB-2 1 item
  111. PDK-1 1 item
  112. Histone Acetyltransferases (HATs) 1 item
  113. Prk 1 item
  114. ITK 1 item
  115. NUAK 1 item
  116. DCLK2 1 item
  117. PTK 1 item
  118. phosphatidylinositol kinase 1 item
  119. Lck 1 item
  120. Flk1 2item
  121. glutamate release 1 item
  122. FGR 1 item
  123. YES 2item
  124. Fyn 2item
  125. ARG 1 item
  126. PKD 1 item
  127. enoyl-acyl-carrier protein reductase 1 item
  128. Rho-kinase 1 item
  129. tropomyosin receptor kinase 1 item
  130. SK 1 item
  131. PPK 1 item
  132. c-Syk 1 item
  133. CDK1/CyclinB 1 item
  134. PIM1 kinase 1 item
  135. phospholipase A2 1 item
  136. ATM 1 item
  137. PIKfyve 1 item
  138. Insulin Receptor 1 item
Reported Experiments
  1. Animal Experiments 274item
  2. Cell Experiments 200item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 16item
  3. Adrenocortical Carcinoma 2item
  4. Advanced Renal Cell Carcinoma 1 item
  5. Bladder Cancer 4item
  6. Bladder Carcinoma 1 item
  7. B-lymphoid Malignancies 1 item
  8. Breast Cancer 43item
  9. Cancer 195item
  10. Cervical Cancer 4item
  11. Cholangiocarcinoma 2item
  12. Chronic Lymphocytic Leukemia 2item
  13. Clear Cell Renal Cell Carcinoma 1 item
  14. Colon Cancer 19item
  15. Colon Carcinoma 2item
  16. Colorectal Cancer 19item
  17. Glioblastoma 16item
  18. Glioma 6item
  19. Hepatocellular Carcinoma 4item
  20. HIV Infections 1 item
  21. Immunological Diseases 1 item
  22. Inflammatory Bowel Disease 1 item
  23. Inflammatory Diseases 4item
  24. Leukemia 8item
  25. Liver Cancer 3item
  26. Lung Cancer 15item
  27. Lung Carcinoma 3item
  28. Lymphoma 9item
  29. Mantle Cell Lymphoma 1 item
  30. Melanoma 12item
  31. Multiple Myeloma 6item
  32. Myelofibrosis 1 item
  33. Myeloma 1 item
  34. Neuroblastoma 2item
  35. Non-small Cell Lung Cancer 5item
  36. Non-small Cell Lung Carcinoma 1 item
  37. Ovarian Cancer 14item
  38. Pancreatic Cancer 22item
  39. Prostate Cancer 17item
  40. Psoriasis 1 item
  41. Pulmonary Arterial Hypertension 1 item
  42. Renal Cancer 3item
  43. Renal Cell Carcinoma 5item
  44. Rheumatoid Arthritis 5item
  45. Thyroid Cancer 5item
  46. Type 2 Diabetes 2item